Clinical trial

The PREDICT Registry:

NCT03448926

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2018-02-27

PhaseN/A

Study timeline

Study start (actual)2018-02-27Date precision: day

Registry last updated2026-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

DCISverified · MONDO: ductal breast carcinoma in situ

Stage 0 Breast Cancerverified · MONDO: breast carcinoma in situ

Ductal Breast Carcinoma In Situverified · MONDO: ductal breast carcinoma in situ

Interventions

Treatment recommendation surveysOTHER

7-gene biosignatureDEVICE

Sponsors & collaborators

PreludeDxlead sponsor

Mapped research locations

New YorkNew York, United States2 TampaFlorida, United States2 HoustonTexas, United States1 BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 NashvilleTennessee, United States1 ClevelandOhio, United States1 PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03448926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.